Preview

FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 14, No 2 (2021) Comparative effectiveness of simultaneous and staged operations in patients with atherosclerotic lesions of carotid and coronary arteries Abstract  similar documents
A. B. Ismoilova, N. M.U. Sultanbaeva, A. A. Abdurakhmanov, Sh. Z. Umarova, D. Kh. Dzhalalova, S. Ch. Dzhalalov
 
Vol 14, No 4 (2021) Machine learning based on laboratory data for disease prediction Abstract  similar documents
A. V. Gusev, R. E. Novitskiy, A. A. Ivshin, A. A. Alekseev
 
Vol 18, No 2 (2025) Analysis of fatty acid profiles of micronutrients and pharmaceuticals based on omega-3 polyunsaturated fatty acid extracts from natural sources Abstract  similar documents
I. Yu. Torshin, O. A. Gromova, A. A. Garanin
 
Vol 15, No 4 (2022) Historical milestones of the invention and use of placebo Abstract  similar documents
A. N. Koterov
"... терапевтического, так и экспериментального плацебо. В первом случае пионерами должны быть названы A. Sutherland ..."
 
Vol 14, No 4 (2021) Application of medical products: mandatory requirements, supervision of their compliance Abstract  similar documents
O. A. Makhova
 
Vol 16, No 4 (2023) DMOADs and DMARDs in the treatment of patients with joint and spine diseases Abstract  PDF (Eng)  similar documents
O. A. Shavlovskaya
 
Vol 18, No 2 (2025) Pharmacoeconomic study of oral anticancer therapy: results of combined ABC/VEN and frequency analysis Abstract  similar documents
J. A. Agafonova
 
Vol 14, No 2 (2021) Survey-based evaluation of the awareness of pharmaceutical specialists on the pharmacotherapy of climacteric syndrome Abstract  similar documents
M. A. Chernyavskaya, I. A. Narkevich
 
Vol 16, No 4 (2023) Development of approaches to the evaluation of pharmacotherapy effectiveness for chronic hepatitis C Abstract  similar documents
I. A. Narkevich, E. A. Tsitlionok
 
Vol 17, No 2 (2024) Clinical and economic assessment of using topical bacterial lysate Imudon® for the treatment and prevention of acute upper respiratory tract infections in children Abstract  similar documents
A. R. Kasimova, A. S. Kolbin
 
Vol 17, No 2 (2024) Clinical and economic assessment of using IRS®19 for the treatment and prevention of acute respiratory infections in children Abstract  similar documents
A. S. Kolbin, A. R. Kasimova
 
Vol 15, No 1 (2022) The real practice of clinical and economic research of drugs included in the Federal Program of High-Cost Nosologies Abstract  similar documents
A. S. Kolbin, Yu. M. Gomon, A. R. Kasimova, A. A. Kurylev, A. E. Bem
 
Vol 18, No 2 (2025) Data analysis of medicines aimed at health technology assessment within the activities of the “Circle of Kindness” Foundation from 2021 to 2024 Abstract  similar documents
V. V. Omelyanovskiy, A. A. Kingshott, T. S. Teptsova, P. A. Mukhortova, A. G. Kharitonova, S. I. Zinadinov, L. O. Krekhtunova, N. A. Aldushchenko, A. А. Kozak, V. A. Ryagina
 
Vol 15, No 2 (2022) Clinical study of real-time polymerase chain reaction test kit for SARS-CoV-2 ribonucleic acids detection Abstract  similar documents
M. Yu. Dmitryukova, A. A. Golod, M. E. Senina, A. E. Gushchin
 
Vol 14, No 2 (2021) Effect of vitamin D intake on quality of life parameters in office workers Abstract  similar documents
A. T. Sharman, Sh. K. Adambekov, A. A. Imandosova, G. F. Elemesova
 
Vol 14, No 1 (2021) History of controlled trials in medicine: real priorities are little-known. Report 1. Basic concepts, terms, and disciplines that use medical experiment: historical and philosophical sources Abstract  similar documents
A. N. Koterov, O. A. Tikhonova, L. N. Ushenkova, A. P. Biryukov
 
Vol 15, No 1 (2022) Study of methods for state regulation of prices and costs of the health care system for medicines in the United Kingdom Abstract  similar documents
A. A. Leshkevich, D. S. Yurochkin, Z. M. Golant, I. A. Narkevich
 
Vol 14, No 3 (2021) History of controlled trials in medicine: real priorities are little-known. Report 2. From early experiments to the present day: without alternation and randomization Abstract  similar documents
A. N. Koterov, O. A. Tikhonova, L. N. Ushenkova, A. P. Biryukov
 
Vol 14, No 4 (2021) Economic burden of chronic viral hepatitis C Abstract  similar documents
R. A. Yakhina, I. A. Lakman, D. A. Valishin, R. Kh. Bakhitova
 
Vol 14, No 4 (2021) History of controlled trials in medicine: real priorities are little-known. Report 3. Quasi-randomized and randomized trials in humans and animals Abstract  similar documents
A. N. Koterov, O. A. Tikhonova, L. N. Ushenkova, A. P. Biryukov
"... according to the table of random numbers, was J.A. Bell, 1941 (USA). Often referred to as the ‘new era in CT ..."
 
Vol 16, No 3 (2023) Retrospective pharmacoeconomic study of antibiotic therapy in community-acquired pneumonia Abstract  similar documents
A. A. Taube, T. V. Alexandrova, O. A. Demidova, M. V. Zhuravleva
 
Vol 17, No 3 (2024) Chemoproteomic analysis of the pharmacological properties of vitamin В12 derivatives Abstract  similar documents
I. Yu. Torshin, O. A. Gromova, I. A. Dereven’kov, L. A. Maiorova
 
Online First Biosensors for measuring nitric oxide NO levels in biosubstrates: a systematic analysis Abstract  similar documents
I. Yu. Torshin, O. A. Gromova, L. A. Mayorova, A. N. Gromov
 
Vol 18, No 2 (2025) Comprehensive analysis of the interrelationships between somatometric, biochemical, and clinical indicators reflecting the condition of patients with chronic kidney disease Abstract  similar documents
I. Yu. Torshin, N. Z. Bashun, O. A. Gromova, A. V. Chekel, A. A. Levchuk, S. N. Lazarevich
 
Vol 15, No 3 (2022) Prospects for the use of chondroitin sulfate and glucosamine sulfate in the treatment of patients with obesity-associated osteoarthritis (metabolic syndrome) Abstract  similar documents
I. Yu. Torshin, О. A. Gromova, A. M. Lila
 
Vol 16, No 1 (2023) Systematic computer analysis of the pharmacology of bioflavonoids in the context of increasing the body's antiviral defenses Abstract  similar documents
O. A. Gromova, I. Yu. Torshin, A. G. Chuchalin
 
Vol 14, No 2 (2021) Systematic computer analysis of published literature on nutritional support for vaccination Abstract  similar documents
A. G. Chuchalin, I. Yu. Torshin, O. A. Gromova
 
Vol 13, No 4 (2020) Evaluation of the economic effect of biological therapy in patients with severe COVID-19 and cytokine storm Abstract  similar documents
M. Yu. Frolov, A. S. Salasyuk, V. A. Rogov
 
Vol 14, No 4 (2021) Hepatoprotective effects of chondroitin sulfate and glucosamine sulfate Abstract  similar documents
I. Yu. Torshin, A. M. Lila, O. A. Gromova
 
Vol 14, No 4 (2021) Prospects of using chondroprotectors for the treatment of pulmonary pathology Abstract  similar documents
I. Yu. Torshin, O. A. Gromova, A. G. Chuchalin
 
Vol 16, No 2 (2023) Analysis of social and economic aspects of using prolonged forms of opioid analgesics for the treatment of chronic pain syndrome in cancer patients Abstract  similar documents
E. A. Pyadushkina, E. V. Derkach, A. V. Palekhov
 
Vol 16, No 3 (2023) The prospects for the use of vitamin B12 derivatives in pharmacology Abstract  similar documents
I. Yu. Torshin, O. A. Gromova, L. A. Maiorova
 
Vol 16, No 3 (2023) Clinical and economic assessment of feasibility of using quadritherapy in patients with reduced ejection fraction chronic heart failure in medical organizations of the Moscow Region Abstract  similar documents
A. D. Ermolaeva, T. N. Ermolaeva, K. A. Kokushkin
 
Vol 16, No 3 (2023) Possibilities of using coenzyme Q10 for the treatment of diseases associated with mitochondrial dysfunction and chronic inflammation Abstract  similar documents
O. A. Gromova, I. Yu. Torshin, A. N. Gromov
 
Vol 16, No 4 (2023) Oncoprotective effects of chondroprotectors: glucosamine, chondroitin sulfate and undenatured type II collagen Abstract  similar documents
I. Yu. Torshin, A. G. Chuchalin, O. A. Gromova
 
Vol 16, No 4 (2023) Possibilities of bioregulation therapy in the treatment of patients with chronic tonsillitis Abstract  similar documents
A. Yu. Ovchinnikov, N. A. Miroshnichenko, Yu. O. Nikolaeva
 
Vol 17, No 3 (2024) Chemoreactomic analysis of the antioxidant properties of vitamin B12 derivatives Abstract  similar documents
I. Yu. Torshin, O. A. Gromova, L. A. Maiorova
 
Vol 17, No 3 (2024) Biologically active supplements overview: regulation, market trends, application, and health impact Abstract  similar documents
A. M. Stepanova, A. N. Plutnitskiy, E. V. Gameeva
 
Vol 17, No 3 (2024) Artificial intelligence: basic terms and concepts, the application in healthcare and clinical medicine Abstract  similar documents
A. I. Lamotkin, D. I. Korabelnikov, I. A. Lamotkin
 
Vol 17, No 4 (2024) Proteomic analysis of synergetic neuroprotective effect of adenosine, thiamine, niacin and cyanocobalamin in pathophysiology of diabetic polyneuropathy Abstract  similar documents
O. A. Gromova, I. Yu. Torshin, A. G. Moiseenok
 
Vol 18, No 1 (2025) Systematic analysis of molecules regulating nitric oxide (NO) metabolism and vascular endothelium condition Abstract  similar documents
I. Yu. Torshin, A. G. Chuchalin, O. A. Gromova
 
Vol 18, No 2 (2025) Chemoreactomic analysis of the drug prototype pilim-1 in comparison with zinc derivatives of nonsteroidal anti-inflammatory drugs Abstract  similar documents
P. A. Galenko-Yaroshevsky, I. Y. Torshin, A. N. Gromov, I. A. Reyer, O. A. Gromova, B. A. Trofimov, L. N. Parshina, R. A. Murashko, O. V. Shelemekh, A. V. Zadorozhniy, V. L. Popkov, A. V. Zelenskaya, I. B. Nektarevskaya, A. V. Sergeeva, A. V. Uvarov, Yu. V. Tovkach, I. V. Sholl
 
Vol 17, No 4 (2024) Chemoreactome prediction of anti-inflammatory, analgesic, ulcerogenic effects of the candidate molecule N-allylimidazole-zinc in comparison with zinc derivatives of nonsteroidal anti-inflammatory drugs Abstract  similar documents
P. A. Galenko-Yaroshevsky, A. V. Sergeeva, I. Yu. Torshin, A. N. Gromov, I. A. Reyer, O. A. Gromova, B. A. Trofimov, L. N. Parshina, R. A. Murashko, A. V. Zadorozhniy, A. V. Zelenskaya, N. S. Sergeev, Yu. V. Tovkach, O. N. Gulevskaya, I. V. Sholl
 
Vol 13, No 4 (2020) The social-economic burden of spinal muscular atrophy in Russia Abstract  similar documents
A. S. Kolbin, D. V. Vlodavets, A. A. Kurylev, Yu. Ye. Balykina, M. A. Proskurin, S. A. Mishinova, O. Yu. Germanenko, N. Yu. Kolbina
 
Vol 16, No 2 (2023) Improving the model of payment for medical care for chronic viral hepatitis C in the framework of the implementation of the Program of State Guarantees of Free Provision of Medical Care to Citizens for 2023 and for the planned period of 2024–2025 Abstract  similar documents
V. V. Omelyanovskiy, I. A. Zheleznyakova, A. V. Zuev, O. S. Plakhotnik, O. A. Volkova, L. M. Davydova, G. V. Trifonova, E. V. Semakova, E. A. Prokhorovich, A. S. Volkova
 
Vol 17, No 1 (2024) Chemoreactome screening of aquacobalamin and heptamethyl ester of cyanoaquacobyrinic acid cytotoxic effects on tumor cells with experimental confirmation on BT-474 and A549 cell Abstract  similar documents
I. Yu. Torshin, M. V. Filimonova, O. A. Gromova, L. A. Maiorova, M. A. Sorokina, D. E. Frolova, A. N. Gromov, I. A. Reyer
"... duct carcinoma), and A549 (lung carcinoma) cell lines. Dicyanocobyric acid heptamethyl ester ((CN)2Cby ..."
 
Vol 17, No 1 (2024) Chemoreactomic analysis of acyzole in comparison with zinc derivatives of nonsteroidal anti-inflammatory drugs Abstract  similar documents
P. A. Galenko-Yaroshevsky, I. Yu. Torshin, A. N. Gromov, O. A. Gromova, R. A. Murashko, A. V. Zelenskaya, L. O. Alukhanyan, O. V. Shelemekh
 
Online First Antitumor effects of vitamin B12 in vitro, in vivo, in silico Abstract  similar documents
O. A. Gromova, D. E. Frolova, I. Yu. Torshin, M. V. Filimonova, M. A. Sorokina, I. A. Reyer, O. A. Limanova, L. E. Fedotova, L. A. Maiorova
"... . Cell lines BT-474 (breast ductal carcinoma) and A549 (lung carcinoma) were used as an in vitro cell ..."
 
Vol 16, No 1 (2023) Compounding pharmacy regulations: experience of the North American pharmaceutical market Abstract  similar documents
D. D. Mamedov, D. S. Yurochkin, A. A. Leshkevich, S. E. Erdni-Garyaev, Z. M. Golant, I. A. Narkevich
 
Vol 16, No 1 (2023) Cost-effectiveness analysis of using atorvastatin, simvastatin, ezetimibe, alirocumab, evolocumab, inclisiran in adults with very high cardiovascular risk under the preferential drug provision program Abstract  similar documents
T. O. Bessonova, P. A. Mukhortova, R. A. Teryan, A. D. Bagdasarov, N. Z. Musina
 
1 - 50 of 174 Items 1 2 3 4 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)